| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Report |
1 Department of Radiology, Wake Forest University School of Medicine, Medical
Center Blvd., Winston-Salem, NC 27157-1088.
2 Department of Internal Medicine, Wake Forest University School of Medicine,
Winston-Salem, NC 27157-1088.
OBJECTIVE. The purpose of this article is to illustrate the CT findings in patients with hepatic metastases from a gastrointestinal stromal tumor who were treated with STI-571.
CONCLUSION. Hepatic metastases from gastrointestinal stromal tumors that respond to treatment with STI-571 can appear as near-cystic components with well-defined borders on contrast-enhanced CT. Most metastases became smaller. These metastases resemble simple cysts, but density measurements may differentiate them from one another.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Escudier, N. Lassau, E. Angevin, J. C. Soria, L. Chami, M. Lamuraglia, E. Zafarana, V. Landreau, B. Schwartz, E. Brendel, et al. Phase I Trial of Sorafenib in Combination with IFN {alpha}-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma Clin. Cancer Res., March 15, 2007; 13(6): 1801 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lassau, M. Lamuraglia, L. Chami, J. Leclere, S. Bonvalot, P. Terrier, A. Roche, and A. Le Cesne Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. Am. J. Roentgenol., November 1, 2006; 187(5): 1267 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K M Linton, M B Taylor, and J A Radford Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases Br. J. Radiol., August 1, 2006; 79(944): e40 - e44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Warakaulle and F. Gleeson MDCT Appearance of Gastrointestinal Stromal Tumors After Therapy with Imatinib Mesylate Am. J. Roentgenol., February 1, 2006; 186(2): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Ryu, J.-L. Lee, H. M. Chang, T. W. Kim, H. J. Kang, H. J. Sohn, J. S. Lee, and Y.-K. Kang Patterns of Progression in Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate Jpn. J. Clin. Oncol., January 1, 2006; 36(1): 17 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shankar, E. vanSonnenberg, J. Desai, P. J. DiPiro, A. Van Den Abbeele, and G. D. Demetri Gastrointestinal Stromal Tumor: New Nodule-within-a-Mass Pattern of Recurrence after Partial Response to Imatinib Mesylate Radiology, June 1, 2005; 235(3): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sandrasegaran, A. Rajesh, J. Rydberg, D. A. Rushing, F. M. Akisik, and J. D. Henley Gastrointestinal Stromal Tumors: Clinical, Radiologic, and Pathologic Features Am. J. Roentgenol., March 1, 2005; 184(3): 803 - 811. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Yang, D. H. Jung, H. Kim, J. H. Kang, S. H. Kim, J. H. Kim, and H. Y. Hwang Retroperitoneal Cystic Masses: CT, Clinical, and Pathologic Findings and Literature Review RadioGraphics, September 1, 2004; 24(5): 1353 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Kim, J. M. Lee, K. R. Son, S. H. Kim, K. H. Lee, K. W. Kim, M. Lee, J. K. Han, and B. I. Choi Gastrointestinal Stromal Tumors of the Duodenum: CT and Barium Study Findings Am. J. Roentgenol., August 1, 2004; 183(2): 415 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Antoch, J. Kanja, S. Bauer, H. Kuehl, K. Renzing-Koehler, J. Schuette, A. Bockisch, J. F. Debatin, and L. S. Freudenberg Comparison of PET, CT, and Dual-Modality PET/CT Imaging for Monitoring of Imatinib (STI571) Therapy in Patients with Gastrointestinal Stromal Tumors J. Nucl. Med., March 1, 2004; 45(3): 357 - 365. [Abstract] [Full Text]
|
|
|
|
 |
|
 P Reichardt, U Schneider, C Stroszczynski, D Pink, and P Hohenberger Molecular response of gastrointestinal stromal tumour after treatment with tyrosine kinase inhibitor imatinib mesylate J. Clin. Pathol., February 1, 2004; 57(2): 215 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gayed, T. Vu, R. Iyer, M. Johnson, H. Macapinlac, N. Swanston, and D. Podoloff The Role of 18F-FDG PET in Staging and Early Prediction of Response to Therapy of Recurrent Gastrointestinal Stromal Tumors J. Nucl. Med., January 1, 2004; 45(1): 17 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zonios, M. Soula, A. J. Archimandritis, K. Revenas, M. Y. M. Chen, R. E. Bechtold, and P. D. Savage Cystlike Hepatic Metastases from Gastrointestinal Stromal Tumors Could Be Seen Before Any Treatment Am. J. Roentgenol., July 1, 2003; 181(1): 282 - 282. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
